ERVW-1 and infection: By contrast with CD8+ T-cell responses, neutralizing antibody (NAb) responses do not typically reach detectable levels until several months after infection [14,15] and the high degree of variability of the viral envelope protein [16] is commonly used to question their utility in controlling infection (e.g. [17]).